Literature DB >> 16694203

FIBRINOLYTIC ACTIVITY OF HEMOLYTIC STREPTOCOCCI. THE DEVELOPMENT OF RESISTANCE TO FIBRINOLYSIS FOLLOWING ACUTE HEMOLYTIC STREPTOCOCCUS INFECTIONS.

W S Tillett1, L B Edwards, R L Garner.   

Abstract

Year:  1934        PMID： 16694203      PMCID： PMC435982          DOI： 10.1172/JCI100579

Source DB:  PubMed          Journal:  J Clin Invest        ISSN： 0021-9738            Impact factor:   14.808


× No keyword cloud information.
  27 in total

1.  Immunochemical studies and complete amino acid sequence of the streptokinase from Streptococcus pyogenes (group A) M type 12 strain A374.

Authors:  H Ohkuni; Y Todome; H Suzuki; M Mizuse; N Kotani; K Horiuchi; N Shikama; A Tsugita; K H Johnston
Journal:  Infect Immun       Date:  1992-01       Impact factor: 3.441

2.  IN VITRO LIQUEFACTION OF HUMAN BLOOD CLOTS BY METABOLITES OF BACILLUS SUBTILIS.

Authors:  I R SHIMI; G M IMAN; M W KELADA
Journal:  Arch Mikrobiol       Date:  1963-07-18

3.  Mechanism of formation of vascular thrombosis and its treatment with fibrinolysin.

Authors:  E E CLIFFTON
Journal:  J Natl Med Assoc       Date:  1961-09       Impact factor: 1.798

4.  The lysis of artificially induced intravascular clots in man by intravenous infusions of streptokinase.

Authors:  A J JOHNSON; W R McCARTY
Journal:  J Clin Invest       Date:  1959-09       Impact factor: 14.808

5.  Streptokinase; 'streptococcal enzymatic debridement'.

Authors:  S TAYLOR
Journal:  Postgrad Med J       Date:  1950-07       Impact factor: 2.401

6.  The relationship between acute rheumatism and streptococcal antifibrinolysin.

Authors:  C B Perry
Journal:  Arch Dis Child       Date:  1939-03       Impact factor: 3.791

7.  THE FIBRINOLYTIC ACTIVITY OF HEMOLYTIC STREPTOCOCCI.

Authors:  W S Tillett
Journal:  Bacteriol Rev       Date:  1938-12

8.  STUDIES OF STREPTOCOCCAL FIBRINOLYSIS. II. THE INHIBITION OF STREPTOCOCCAL FIBRINOLYSIS BY ANTIFIBRINOLYSIN AND ANTIPROTEASE.

Authors:  M H Kaplan
Journal:  J Clin Invest       Date:  1946-05       Impact factor: 14.808

9.  THE EFFECT IN PATIENTS OF STREPTOCOCCAL FIBRINOLYSIN (STREPTOKINASE) AND STREPTOCOCCAL DESOXYRIBONUCLEASE ON FIBRINOUS, PURULENT, AND SANGUINOUS PLEURAL EXUDATIONS.

Authors:  W S Tillett; S Sherry
Journal:  J Clin Invest       Date:  1949-01       Impact factor: 14.808

10.  Profiling the immune responses of human patients treated with recombinant streptokinase after myocardial infarct.

Authors:  O Reyes; I Torrens; A G Ojalvo; A Seralena; H E Garay
Journal:  Mol Divers       Date:  2004       Impact factor: 2.943
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.